Product Information
COLISTIMETHATE 150 MG VIAL is a generic product labeled by Xellia Pharmaceuticals USA LLC, priced at $15.4867 per EA under NDC 70594002301. Its NADAC has been published 36 times since Dec 17, 2025.
FDA first approved this application on May 29, 2015. Its Orange Book therapeutic-equivalence code is AP.
Strength
150 mg/1
Manufacturer
Xellia Pharmaceuticals USA LLCNDC
70594002301
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
5/20/2026
Active Ingredients
COLISTIMETHATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205356FDA Approved
5/29/2015
TE Code
AP
On Market Since
2/20/2022
Pharmacological Classes
Price Statistics
The NADAC for COLISTIMETHATE 150 MG VIAL has been published 36 times since Dec 17, 2025, and over the history we have for it it has declined 13.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.4867 per EA |
|---|---|
| All-time high | $17.9620 (Feb 11, 2026) |
| All-time low | $15.4867 (May 20, 2026) |
| 52-week high | $17.9620 |
| 52-week low | $15.4867 |
| Median price | $16.3455 |
| Average price | $16.5531 |
| Largest weekly change | -7.0% (Mar 18, 2026) |
| Weeks tracked | 36 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COLISTIMETHATE 150 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for COLISTIMETHATE 150 MG VIAL, manufactured by Xellia Pharmaceuticals USA LLC, is $15.4867 per EA (NDC 70594002301), effective Aug 19, 2026.
How has the price of COLISTIMETHATE 150 MG VIAL changed over time?
Over the history we have for it, the NADAC for COLISTIMETHATE 150 MG VIAL has declined 13.8%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for COLISTIMETHATE 150 MG VIAL?
Since Dec 17, 2025, the NADAC for COLISTIMETHATE 150 MG VIAL has ranged from a low of $15.4867 (May 20, 2026) to a high of $17.9620 (Feb 11, 2026), with a median of $16.3455 per EA.
Are there cheaper alternatives to COLISTIMETHATE 150 MG VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as COLISTIMETHATE 150 MG VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures COLISTIMETHATE 150 MG VIAL?
COLISTIMETHATE 150 MG VIAL (NDC 70594002301) is labeled by Xellia Pharmaceuticals USA LLC, and CMS classifies it as a generic product.